Baxter International | BAX - Ebitda



Baxter International reported $325M in EBITDA for its fiscal quarter ending in March of 2025.


Ebitda Change Date
Abbott USD 3.05B 870M Jun/2025
AtriCure USD 15.35M 16.22M Jun/2025
Avanos Medical USD -63900000 85.5M Jun/2025
Baxter International USD 325M 251M Mar/2025
Becton, Dickinson and Co. USD 1.47B 81M Jun/2025
Boston Scientific USD 1.36B 16M Mar/2025
Cooper Companies USD 272.7M 5.8M Jul/2025
Dexcom USD 308.8M 115.1M Jun/2025
Edwards Lifesciences USD 411.3M 15.3M Mar/2025
Fresenius EUR 828M 88M Jun/2025
Globus Medical USD 208.68M 44.48M Jun/2025
Halozyme Therapeutics USD 225.5M 63.51M Jun/2025
ICU Medical USD 100.31M 36.51M Jun/2025
Insulet USD 157.5M 47M Jun/2025
Integra LifeSciences USD -472218000 536.09M Jun/2025
Intuitive Surgical USD 898.7M 317.2M Jun/2025
J&J USD 7.88B 1.76B Mar/2025
Laboratory Of America USD 633.6M 135.6M Jun/2025
Masimo USD 72M 17.3M Jun/2025
Medtronic USD 2.31B 400M Jul/2025
Merit Medical Systems USD 83.96M 10.65M Jun/2025
Quest Diagnostics USD 570M 65M Jun/2025
Smith & Nephew USD 796M 48.8M Jun/2025
Stryker USD 1.46B 49M Jun/2025
Tandem Diabetes Care USD -1851000 28.33M Jun/2025
Teleflex USD 222.67M 27.85M Jun/2025
Terumo JPY 77.07B 31.43B Jun/2025
Zimmer Biomet Holdings USD 575.7M 26.1M Jun/2025